RVTY
Revvity Inc.
NYSE: RVTY · HEALTHCARE · DIAGNOSTICS & RESEARCH
$151.60
-3.44% today
Updated 2026-11-02
Market cap
$17.72B
P/E ratio
75.97
P/S ratio
6.08x
EPS (TTM)
$2.09
Dividend yield
0.18%
52W range
$81 – $166
Volume
2.0M
WallStSmart proprietary scores
52
out of 100
Grade: C
Hold
Investment rating
3.3
Growth
D7.0
Quality
B+5.5
Profitability
C+5.0
Valuation
C+5/9
Piotroski F-Score
Moderate
2.0
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →253 stocks currently score above 75
Price targets
Analyst target
$147.53
-2.68%
12-Month target
$61.88
-59.18%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy5 Buy11 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $180.87M — positive
+ Debt/equity 0.46x — low leverage
Risks
- P/E 75.97x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.31B | $2.75B | $2.76B | $2.86B | $2.91B |
| Net income | $569.18M | $-118.38M | $295.83M | $241.68M | $51.82M |
| EPS | — | — | — | — | $2.09 |
| Free cash flow | $594.18M | $9.90M | $541.65M | $508.25M | $180.87M |
| Profit margin | 17.19% | -4.30% | 10.74% | 8.46% | 8.16% |
Peer comparison
Smart narrative
Revvity Inc. trades at $151.60. representing a P/E of 75.97x trailing earnings. Our Smart Value Score of 52/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 2.00, it sits in the grey zone. TTM revenue stands at $2.91B. with profit margins at 8.16%.
Frequently asked questions
What is Revvity Inc.'s stock price?
Revvity Inc. (RVTY) trades at $151.60, on a P/E of 76.0x and a P/S of 6.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Revvity Inc. overvalued?
Revvity Inc. carries a Smart Value Score of 52/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Revvity Inc. (RVTY)?
The 12-month analyst consensus target is $147.53, about 2.7% below the current $151.60. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Revvity Inc.'s revenue?
Revvity Inc.'s trailing twelve-month revenue is $2.91B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Revvity Inc.'s Altman Z-Score is 2.00, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio6.08x
ROE3.29%
Beta1.06
50D MA$140.08
200D MA$110.49
Shares out0.11B
Float0.10B
Short ratio—
Avg volume2.0M
Performance
1 week-6.34%
1 month+0.05%
3 months+36.10%
YTD+56.69%
1 year+63.06%
3 years—
5 years—